Send us a text

In this episode of Beyond the Wheeze, I’m joined by Dr. Meraj Khan, a clinical research scientist and CEO of DigiBiomics. We dive into how AI is changing the landscape of respiratory health and what it could mean for people living with asthma. Dr. Khan walks me through his career journey, the story behind DigiBiomics, and how their AI-driven diagnostics — including a tool called LungSense — are helping detect lung disease earlier and personalize care for patients.

We get into the potential of AI in asthma management, what advancements might be around the corner, and how collaborations across healthcare and tech are moving the field forward. We also talk about the ethical challenges that come with AI in medicine, and Dr. Khan shares some solid advice for anyone looking to work at the intersection of healthcare and technology.

If you’re curious about where asthma care is headed or how AI might fit into future treatment plans, this is a conversation worth hearing.

Visit DigiBiomics website by clicking here, or connect with Dr. Khan on LinkedIn, here.

Timestamps:

01:25 Introduction and Guest Welcome
02:22 Dr. Khan’s Career Journey
04:16 The Mission Behind DigiBiomics
06:37 AI’s Role in Respiratory Health
07:25 Future of AI in Asthma Care
09:33 DigiBiomics Services and Personalized Care
13:29 Collaborations and Global Impact
18:43 Ethics and Challenges in AI Adoption
28:21 Personal Reflections and Advice
34:18 Final Thoughts and Conclusion

Connect with us (@BeyondTheWheeze):

• Check us out on Instagram
• Follow Beyond the Wheeze on LinkedIn
• Connect with us on TikTok
• Follow us on Facebook
• Speaking services, media, blog & news on our website
• Email Josh directly at [email protected].

Are video podcasts more your thing? Check us out on YouTube!

Visit Asthma Canada, or the Lung Health Foundation, to see how you can get involved today.